This study tested the hypothesis that pioglitazone reduces endothelin-1 activity in the forearm vasculature in non-diabetic patients with hypertension or hypercholesterolemia and variable degrees of insulin resistance.
Campia, U., Matuskey, L., Tesauro, M., Cardillo, C., Panza, J., PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia, <<ATHEROSCLEROSIS>>, 2014; 234 (2): 436-440. [doi:10.1016/j.atherosclerosis.2014.03.035] [http://hdl.handle.net/10807/64371]
PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia
Cardillo, Carmine;
2014
Abstract
This study tested the hypothesis that pioglitazone reduces endothelin-1 activity in the forearm vasculature in non-diabetic patients with hypertension or hypercholesterolemia and variable degrees of insulin resistance.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
